Low ARF expression without deleterious mutations in the CDKN2a locus is found in non-small cell lung cancer (NSCLC), implying that post-translational regulation of ARF may be involved in cancer development (Table 2). Here, CDKN2A is linked to non-small cell lung carcinoma.